investor relations

MONETT, Mo., Aug. 15, 2017 /PRNewswire/ -- Jack Henry & Associates, Inc. (NASDAQ: JKHY), a leading provider of technology solutions and payment processing services primarily for the financial services industry, today announced fourth quarter and full year fiscal 2017 results. 

Revenue for the quarter ended June 30, 2017 increased to $383.8 million, a 5% increase over the fourth quarter of fiscal 2016.  Gross profit also increased 2% to $164.4 million.  Net income decreased 23% to $64.7 million, or $0.83 per diluted share, due to the gain on the sale of Alogent recognized in the fourth quarter of fiscal 2016, coupled with lower deconversion fees in the fourth quarter of fiscal 2017 compared to the same period of the prior year.

Revenue for the year ended June 30, 2017 increased 6% over the year ended June 30, 2016 to $1,431.1 million, with a gross profit increase of 5% to $612.1 million. Net income totaled $245.8 million, a decrease of 1% over the prior year-to-date period, with diluted earnings per share of $3.14.  The decrease in net income was due to the gain on the sale of Alogent in the prior year. 

According to David Foss, President and CEO, "As we wrap up our FY'17, we are pleased to report another year of record revenue and operating income.  Our combined sales organization ended their year ahead of plan and our sales pipeline is very strong which should position us well for next year.  Additionally, we are pleased that both our employee engagement and customer satisfaction scores continue to be very solid as we enter FY'18."

Operating Results

Revenue, cost of sales, and gross profit results for the quarter and year ended June 30, 2017 were as follows:

• Fourth quarter fiscal 2016 included revenue of $6.1 million from Alogent, which was sold near the end of that quarter. In addition, deconversion fees in the fourth quarter of fiscal 2017 decreased $8.9 million compared to the fourth quarter of the prior year. Excluding Alogent revenue and costs from the prior year, and deconversion fees from both periods, revenue increased 9% and gross profit increased 10%.
• The twelve months ended June 30, 2016 included revenue of $28.4 million from Alogent. Deconversion fees for fiscal 2017 increased $1.9 million. Excluding the Alogent headwind, and deconversion fees from both periods, revenue increased 8% and gross profit increased 9% over the twelve months ended June 30, 2016.
• For the fourth quarter of fiscal 2017, the bank systems and services segment revenue increased 2% to $277.4 million, with a gross margin of 40%, from $272.7 million, with a gross margin of 43%, in the same quarter last year. Excluding Alogent from the fourth quarter of fiscal 2016, bank systems and services segment revenue increased 4% for the quarter. The credit union systems and services segment revenue increased 13% to $106.4 million, with a gross margin of 50%, for the fourth quarter of fiscal 2017 from $94.3 million, with a gross margin of 47%, in the same period a year ago. The increased revenue in the credit union segment was mainly due to an increase in bundled services revenue caused by an increase in terminations of pending products and service obligations on certain contracts allowing for earlier recognition of revenue on our bundled arrangements.
• For the twelve months ended June 30, 2017, bank systems and services segment revenue increased 6% to $1,055.8 million, with a gross margin of 41%, from $996.7 million, with a gross margin of 41%, for the same twelve months of fiscal 2016. Excluding Alogent revenue from the prior year period, bank systems and services revenue increased 9%. Credit union systems and services segment revenue increased 5% to $375.4 million, with a gross margin of 49%, for the year-to-date period, compared to revenue of $358.0 million, with a gross margin of 48%, for the twelve months ended June 30, 2016.

Operating Expenses and Operating Income

Operating income decreased 15% to $98.9 million, or 26% of fourth quarter fiscal 2017 revenue, compared to $116.5 million, or 32% of revenue in the fourth quarter of fiscal 2016.  The decrease in operating income was due to the gain on the sale of Alogent recognized in the fourth quarter of fiscal 2016, coupled with lower deconversion fees in the fourth quarter of fiscal 2017.  Full year operating income increased 2% to $367.7 million, which was 26% of year-to-date revenue, compared to $361.7 million, or 27% of revenue in the twelve months ended June 30, 2016.

• Selling and marketing expenses for the fourth quarter of fiscal 2017 and for the full fiscal year increased over the prior year due mainly to increased commission expense. For the fiscal year, selling and marketing expense remained at a consistent percentage of total revenue.
• Research and development expense for the fourth quarter decreased mainly due to lower losses related to asset sales compared to the prior year quarter. The increase in research and development costs in the year ended June 30, 2017 was primarily due to a 4% increase in headcount, but these costs remained consistent with the prior year as a percentage of total revenue.
• General and administrative expenses increased for both the quarter and year ended June 30, 2017 primarily due to an increase in headcount, but were a consistent percentage of revenue in each period.
• In the fourth quarter of fiscal 2017, we sold our Regulatory Filing products to Fed Reporter. In the fourth quarter of fiscal 2016, we sold our Alogent business ("Alogent") to Antelope Acquisition Co., an affiliate of Battery Ventures.

Net Income

Fourth quarter net income decreased 23% to $64.7 million, or $0.83 per diluted share, compared to $84.3 million, or $1.06 per diluted share, in the fourth quarter of fiscal 2016.  The decrease is due to the gain on the sale of Alogent recognized in the fourth quarter of fiscal 2016, coupled with an $8.9 million decrease in deconversion fees in the fourth quarter of fiscal 2017 compared to the same quarter of the prior year.

Net income for the year ended June 30, 2017 decreased 1% to $245.8 million, or $3.14 per diluted share, compared to $248.9 million or $3.12 per diluted share in fiscal 2016. 

• Provision for income taxes increased in the fourth quarter, with an effective tax rate at 34.4% of income before income taxes, compared to 27.4% for the same quarter of the prior year. The increase in the effective tax rate was due primarily to a significant difference in the book versus tax basis in Alogent stock sold in the fourth quarter of fiscal 2016, causing a decrease in that quarter's effective tax rate.
• For the fiscal year, the effective tax rate increased to 33.0% of income before income taxes from 31.0% for the year ending June 30, 2016, with the increase again being due mainly to the effect of the Alogent sale on the prior year's effective tax rate.
• The adoption of ASU 2016-09 (Improvements to Employee Share-Based Payment Accounting) resulted in an increase in diluted earnings per share of $0.03 for the year ended June 30, 2017.

Effects of Alogent and Deconversion Fees

The table below shows our results for the fourth quarter and fiscal year excluding the impact of Alogent operations and the gain on the sale of Alogent from fiscal 2016 and deconversion fees from each year.

According to Kevin Williams, CFO, "We thought it was important to provide our operating results on a true apples-to-apples comparison without all the noise created by the divestiture of Alogent in the prior year and the early term fees from both fiscal years.  The divestiture created revenue headwinds during the year and had a significant one time gain on the sale and the early term fees are primarily caused by mergers and acquisitions of our customers, which we have no control over.  Therefore, it makes sense to remove both of these to provide a clear picture of our operations."

Balance Sheet and Cash Flow Review

• At June 30, 2017, cash and cash equivalents increased to $114.8 million from $70.3 million at June 30, 2016.
• Trade receivables totaled $276.9 million at June 30, 2017 compared to $253.9 million at June 30, 2016.
• Current and long-term debt totaled $50.0 million at June 30, 2017, an increase from $0.2 million a year ago.
• Total deferred revenue decreased to $511.4 million at June 30, 2017, compared to $521.1 million a year ago.
• Stockholders' equity increased to $1,032.1 million at June 30, 2017, compared to $996.2 million a year ago.

Cash provided by operations totaled $357.3 million in fiscal 2017 compared to $366.4 million last year.  The following table summarizes net cash (in thousands) from operating activities:

Cash used in investing activities for fiscal 2017 totaled $141.6 million, compared to $136.0 million for the same period in fiscal 2016 and included the following:

• The $41.9 million in capital expenditures was mainly for the purchase of computer equipment.

Financing activities used cash of $171.3 million in fiscal 2017 and $308.5 million in fiscal 2016. 

Quarterly Conference Call

The company will hold a conference call on August 16, 2017; at 7:45 a.m. Central Time and investors are invited to listen at www.jackhenry.com.

About Jack Henry & Associates

Jack Henry & Associates, Inc. (NASDAQ: JKHY) is a leading provider of technology solutions and payment processing services primarily for the financial services industry. Its solutions serve more than 9,000 customers nationwide, and are marketed and supported through three primary brands. Jack Henry Banking® supports banks ranging from community banks to multi-billion dollar institutions with information processing solutions.  Symitar® is the leading provider of information processing solutions for credit unions of all sizes. ProfitStars® provides highly specialized products and services that enable financial institutions of every asset size and charter, and diverse corporate entities to mitigate and control risks, optimize revenue and growth opportunities, and contain costs.  Additional information is available at www.jackhenry.com.

Statements made in this news release that are not historical facts are forward-looking information.  Actual results may differ materially from those projected in any forward-looking information.  Specifically, there are a number of important factors that could cause actual results to differ materially from those anticipated by any forward-looking information.  Additional information on these and other factors, which could affect the Company's financial results, are included in its Securities and Exchange Commission (SEC) filings on Form 10-K, and potential investors should review these statements.  Finally, there may be other factors not mentioned above or included in the Company's SEC filings that may cause actual results to differ materially from any forward-looking information.

View original content:http://www.prnewswire.com/news-releases/jack-henry--associates-ends-fiscal-2017-with-6-increase-in-revenue-300504826.html

SOURCE Jack Henry & Associates, Inc.